Clinical Trials Sponsored by Teva Pharma

Total 9045 results

Teva Pharma

Completed

Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines

Metastatic Breast Cancer

Belgium
Rabin Medical Center
Astellas Pharma Inc; Teva Pharma

Unknown

Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus (Advagraf)

Medication Adherence

Israel
Borstkanker Onderzoek Groep
Roche Pharma AG; Teva Pharma

Completed

8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer (Stop&Go)

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Netherlands
Teva Pharma GmbH

Completed

A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.

Pregnancy Rate | Oocytes

Germany
Teva Pharma GmbH

Completed

Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Patient Satisfaction

Germany
University Medical Center Groningen
Teva Pharma

Completed

Effects of QVAR in Smokers With Asthma (OLiVIA)

Asthma

Netherlands
Eva Pharma
DataClin

Completed

Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis (CLEAR)

Active Rheumatoid Arthritis

Egypt
Teva Pharma GmbH
Anfomed GmbH

Completed

Azilect® In Wearing-Off (AIWO) (AIWO)

Parkinson's Disease

Germany
Alexandria University
Eva Pharma

Active, not recruiting

Anti-diabetic Drugs and Fatty Liver Management

Diabetes Mellitus, Type 2 | Fatty Liver, Nonalcoholic

Egypt
Eva Pharma
MARC-CRO

Recruiting

Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt (MIRACLE-ALA)

Polyneuropathy, Diabetic

Egypt
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin Pharma, Inc.; Teva Pharma

Completed

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Adenocarcinoma of the Pancreas | Solid Tumour | Adenocarcinoma of the Colorectal
German Breast Group
Roche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor Pharma

Completed

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Inflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III

Germany
Ain Shams University
Eva Pharma

Not yet recruiting

Alpha Lipoic Acid in Pediatrics on Hemodialysis

Hemodialysis Complication | Pediatric Kidney Disease | Cardiovascular Complication

Egypt
Leslie Zun, MD
Teva Pharma

Unknown

Self Reported Level of Agitation of Patients Presenting to an Emergency Department

Psychiatric Issue

United States
Teva Pharmaceuticals USA
Teva Pharmaceuticals, Inc.

Completed

Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris

Acne Vulgaris

United States
Teva GTC

Completed

Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients

Crohns Disease

Israel
Teva GTC

Completed

Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease

Crohn's Disease

Israel
Teva GTC

Withdrawn

Open Label Extension Study to Protocol C2/13/DR-6MP-02 (OLE)

Crohn's Disease
Teva GTC

Terminated

One Year Extension Study To Protocol C2/5/TZ:MS-05

Multiple Sclerosis | Spasticity

Israel
Teva GTC

Completed

Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity

Muscle Spasticity

Israel
Teva GTC

Terminated

Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease

Crohn's Disease

Israel
Teva GTC

Completed

Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)

Traumatic Brain Injury

Israel
Genuine Research Center, Egypt
Eva Pharma

Completed

Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)

Healthy

Egypt
Genuine Research Center, Egypt
Eva Pharma

Completed

Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus Paxlovid 150 + 100 mg Film Coated Tablets (Pfizer Europe, Belgium)

Healthy

Egypt
Genuine Research Center, Egypt
Eva Pharma

Completed

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

Healthy

Egypt
German Breast Group
GlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USA

Completed

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (GeparSixto)

Inflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IV

Germany
Genuine Research Center, Egypt
Eva Pharma

Completed

Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Industries, Egypt) and Stromectol 2*3 mg Tablets (Merck Sharp & Dohme B.V., Haarlem, The Netherlands)

Healthy

Egypt
Genuine Research Center, Egypt
Eva Pharma

Completed

Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)

Healthy

Egypt
Teva Pharmaceuticals USA
Teva Pharmaceuticals Development, Inc.

Completed

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Chronic Urticaria

United States
Teva Branded Pharmaceutical Products R&D, Inc.
Nuvelution TS Pharma, Inc.

Terminated

Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents (ARTISTS)

Tourette Syndrome

United States, Argentina, Australia, Canada, Colombia, Denmark, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Serbia, Spain, Ukraine
Teva Branded Pharmaceutical Products R&D, Inc.
Nuvelution TS Pharma, Inc.

Completed

A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS) (ARTISTS2)

Tourette Syndrome

United States, Argentina, Australia, Colombia, Hungary, Italy, Korea, Republic of, Mexico, Poland, Ukraine
Teva Branded Pharmaceutical Products R&D, Inc.
Nuvelution TS Pharma, Inc.

Completed

Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents (ARTISTS1)

Tourette Syndrome

United States, Canada, Denmark, Russian Federation, Serbia, Spain
Teva Pharmaceuticals USA

Terminated

Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients

Seasonal Allergic Rhinitis

United States
Teva Pharmaceuticals USA

Completed

Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Teva Pharmaceuticals USA

Withdrawn

An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.

Evaluation of QTc Interval
Teva Pharmaceuticals USA

Completed

Pravastatin Sodium 40 mg Tablets Food Challenge Study

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Seasonal Allergic Rhinitis
Teva Pharmaceuticals USA

Completed

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions

Bioequivalence

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects

Healthy

United States
Teva Pharmaceuticals USA

Completed

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Valacyclovir 1000 mg Tablet Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis

Bacterial Vaginosis

United States
Teva Pharmaceuticals USA

Completed

Terbinafine HCl 250 mg Tablet Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Tablets Under Fed Conditions

Healthy

Canada

3

Subscribe